Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2127

1.

Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.

Kobayashi Z, Arai T, Kawakami I, Yokota O, Hosokawa M, Oshima K, Niizato K, Shiraishi A, Akiyama H, Mizusawa H.

Psychogeriatrics. 2018 Jul;18(4):307-312. doi: 10.1111/psyg.12334.

PMID:
30133939
2.

Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease.

Ebbert MTW, Farrugia SL, Sens JP, Jansen-West K, Gendron TF, Prudencio M, McLaughlin IJ, Bowman B, Seetin M, DeJesus-Hernandez M, Jackson J, Brown PH, Dickson DW, van Blitterswijk M, Rademakers R, Petrucelli L, Fryer JD.

Mol Neurodegener. 2018 Aug 21;13(1):46. doi: 10.1186/s13024-018-0274-4.

3.

The Head Turning Sign in Dementia and Mild Cognitive Impairment: Its Relationship to Cognition, Behavior, and Cerebrospinal Fluid Biomarkers.

Durães J, Tábuas-Pereira M, Araújo R, Duro D, Baldeiras I, Santiago B, Santana I.

Dement Geriatr Cogn Disord. 2018;46(1-2):42-49. doi: 10.1159/000486531. Epub 2018 Aug 9.

PMID:
30092564
4.

Early-stage right temporal lobe variant of frontotemporal dementia: 3 years of follow-up observations.

Okada A, Ohyama K, Ueda T.

BMJ Case Rep. 2018 Jun 29;2018. pii: bcr-2018-224431. doi: 10.1136/bcr-2018-224431.

PMID:
29960960
5.

TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Majumder V, Gregory JM, Barria MA, Green A, Pal S.

BMC Neurol. 2018 Jun 28;18(1):90. doi: 10.1186/s12883-018-1091-7. Review.

6.

Clinical exome sequencing in dementias: a preliminary study.

Zalar B, Maver A, Kovanda A, Peterlin A, Peterlin B.

Psychiatr Danub. 2018 Jun;30(2):216-219. doi: 10.24869/psyd.2018.216.

7.

Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.

Arrant AE, Nicholson AM, Zhou X, Rademakers R, Roberson ED.

Mol Neurodegener. 2018 Jun 22;13(1):32. doi: 10.1186/s13024-018-0264-6.

8.

Lost in Translation: Evidence for Protein Synthesis Deficits in ALS/FTD and Related Neurodegenerative Diseases.

Lehmkuhl EM, Zarnescu DC.

Adv Neurobiol. 2018;20:283-301. doi: 10.1007/978-3-319-89689-2_11. Review.

PMID:
29916024
9.

An Epigenetic Spin to ALS and FTD.

Ebbert MTW, Lank RJ, Belzil VV.

Adv Neurobiol. 2018;20:1-29. doi: 10.1007/978-3-319-89689-2_1. Review.

PMID:
29916014
10.

Molecular Genetics of Frontotemporal Dementia Elucidated by Drosophila Models-Defects in Endosomal⁻Lysosomal Pathway.

Vandal SE, Zheng X, Ahmad ST.

Int J Mol Sci. 2018 Jun 9;19(6). pii: E1714. doi: 10.3390/ijms19061714. Review.

11.

Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.

Cortés-Vicente E, Turon-Sans J, Gelpi E, Clarimón J, Borrego-Écija S, Dols-Icardo O, Illán-Gala I, Lleó A, Illa I, Blesa R, Al-Chalabi A, Rojas-García R.

Dement Geriatr Cogn Disord. 2018;45(3-4):220-231. doi: 10.1159/000488528. Epub 2018 Jun 8.

PMID:
29886477
12.

Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, Zoing MC, Shibuya K, Geevasinga N, Vucic S, Hodges JR, Ahmed RM, Kiernan MC.

J Neurol. 2018 Aug;265(8):1819-1828. doi: 10.1007/s00415-018-8917-5. Epub 2018 Jun 4.

PMID:
29868980
13.

Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function.

Hagenaars SP, Radaković R, Crockford C, Fawns-Ritchie C; International FTD-Genomics Consortium (IFGC), Harris SE, Gale CR, Deary IJ.

PLoS One. 2018 Jun 1;13(6):e0198187. doi: 10.1371/journal.pone.0198187. eCollection 2018.

PMID:
29856801
Free PMC Article
14.

Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis.

Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, Baird A, Donahue JE, Torabi T, Eliceiri BP, Silverberg GD, Johanson CE.

Fluids Barriers CNS. 2018 May 31;15(1):18. doi: 10.1186/s12987-018-0102-9.

15.

Functional Connectivity Changes in Behavioral, Semantic, and Nonfluent Variants of Frontotemporal Dementia.

Reyes P, Ortega-Merchan MP, Rueda A, Uriza F, Santamaria-García H, Rojas-Serrano N, Rodriguez-Santos J, Velasco-Leon MC, Rodriguez-Parra JD, Mora-Diaz DE, Matallana D.

Behav Neurol. 2018 Apr 1;2018:9684129. doi: 10.1155/2018/9684129. eCollection 2018.

16.

Mutation screening of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis/frontotemporal dementia.

Gu X, Chen Y, Wei Q, Cao B, Ou R, Yuan X, Hou Y, Zhang L, Liu H, Chen X, Shang HF.

Neurobiol Aging. 2018 Aug;68:161.e1-161.e3. doi: 10.1016/j.neurobiolaging.2018.04.010. Epub 2018 Apr 24.

PMID:
29773329
17.

The multifaceted clinical presentation of VCP-proteinopathy in a Greek family.

Papadimas GK, Paraskevas GP, Zambelis T, Karagiaouris C, Bourbouli M, Bougea A, Walter MC, Schumacher NU, Krause S, Kapaki E.

Acta Myol. 2017 Dec 1;36(4):203-206. eCollection 2017 Dec.

18.

Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.

Liu X, Jiao B, Zhang W, Xiao T, Hou L, Pan C, Tang B, Shen L.

Mol Med Rep. 2018 Jul;18(1):461-466. doi: 10.3892/mmr.2018.8962. Epub 2018 May 3.

PMID:
29749507
19.

Targeted exome sequencing reveals homozygous TREM2 R47C mutation presenting with behavioral variant frontotemporal dementia without bone involvement.

Ng ASL, Tan YJ, Yi Z, Tandiono M, Chew E, Dominguez J, Macas M, Ng E, Hameed S, Ting S, Tan EK, Foo JN, Kandiah N.

Neurobiol Aging. 2018 Aug;68:160.e15-160.e19. doi: 10.1016/j.neurobiolaging.2018.04.003. Epub 2018 Apr 16.

PMID:
29748150
20.

Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls.

Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML, Volk AE, Diehl-Schmid J, Prudlo J, Danek A, Landwehrmeyer B, Lauer M, Otto M, Jahn H; FTLDc study group.

PLoS One. 2018 May 10;13(5):e0197329. doi: 10.1371/journal.pone.0197329. eCollection 2018.

Supplemental Content

Loading ...
Support Center